Wyeth to use Ambion's RNA:
This article was originally published in Clinica
Executive Summary
Ambion RNA Diagnostics of Austin, Texas, is to develop and manufacture cGMP-grade RNA for pharmaceutical company Wyeth's vaccine programme. It will supply enough material for clinical trials. Ambion offers on a contract basis RNA synthesis, RNA isolation, diagnostic kits, controls and standards and RNA-based raw materials for bioprocessing.